Search clinical trials for: Amodiaquine suspension

Total 1525 results

Bp Consulting, Inc

Completed

Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)

Intraocular Pressure

United States
Pfizer

Completed

Study of Controlled Release Formulations of CE-224,535 Against the Immediate Release Formulation in Normal Volunteers

Rheumatoid Arthritis

United States
Nova Scotia Health Authority

Terminated

The Effect of Silicone Suspension on Standing Balance for Transfemoral Amputees

Amputee

Canada
Sanofi

Completed

Valproic Acid Sodium Salt in Bipolar Disorder

Bipolar Disorder

Turkey
Medecins Sans Frontieres, Netherlands
University of Oxford; Mahidol University; Disease Control, Department of Health...

Unknown

Effectiveness of Artemisinin Combination Regimens in Falciparum Malaria (ACT)

Uncomplicated Falciparum Malaria

Myanmar
AstraZeneca

Completed

Phase I 2-Way Crossover Study to Assess Relative BA of Tablet Versus Liquid Suspension and Food Effect on Tablet Formulation

Healthy

United States
University Hospital, Ghent

Completed

Pharmacokinetics of Enteral Omeprazole Suspension in Patients With Cerebral Palsy and Mental Retardation

Gastreoesophageal Reflux Disease

Belgium
AstraZeneca

Completed

To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 Suspension

Type 2 Diabetes

United States
AstraZeneca

Completed

Pulmicort Respules(Budesonide Inhalation Suspension) vs Singulair, Children

Asthma
AstraZeneca

Completed

Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial Asthma

Asthma

Japan
Centre Hospitalier Universitaire Vaudois

Completed

Effect of Platelet Rich Plasma and Keratinocyte Suspensions on Wound Healing

Skin Graft

Switzerland
National Malaria Control Programme, Madagascar
Sanofi; Population Services International; Institut Pasteur de Madagascar; Reggio... and other collaborators

Completed

ACT for the Home Management in Malagasy Children

Fever | Suspected Malaria

France
Heidelberg University

Completed

Safety and Efficacy of Methylene Blue Combined With Amodiaquine or Artesunate for Malaria Treatment in Children of Burkina Faso

Malaria

Burkina Faso
Sanofi

Completed

Bioavailability of the Fixed Combination of Amodiaquine and Artesunate Under Fed & Fasted Conditions

Malaria

France
University Hospital Freiburg
Pfizer

Completed

Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders

Conduct Disorder | Oppositional Defiant Disorder

Germany
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg - 42.9 mg/ 5 mL Oral Suspension Under Fasting Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg-42.9 mg/ 5 mL Oral Suspension Under Fed Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fasting Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fed Conditions

Healthy

Canada
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivaelnce Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fed Conditions

Healthy

India
Sanofi

Completed

Paracetamol Oral Paediatric Suspension at 4.8% : Study of Acceptability and Safety.

Pain | Fever

France
Point Biomedical

Completed

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007

Coronary Artery Disease

United States
Point Biomedical

Terminated

Evaluation and Optimization of PB127 Myocardial Perfusion Echocardiography on Ultrasound Systems

Coronary Artery Disease | Healthy

United States
Point Biomedical

Completed

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease

Coronary Artery Disease

United States
Point Biomedical

Completed

Familiarization and Safety Study of PB127 Ultrasound Contrast Agent

Coronary Artery Disease

United States
Point Biomedical

Terminated

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease (POINT II)

Coronary Artery Disease

United States
University of Jena

Unknown

Photodynamic Therapy for Permanent Hair Removal

Hirsutism | Hypertrichosis

Germany
Pfizer

Completed

A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA

Arthritis, Juvenile Rheumatoid

United States, Spain, Belgium, Germany, Mexico, Russian Federation, Slovakia, Peru, Brazil, Canada, Denmark, France, Portugal, Slovenia, Sweden
Karolinska University Hospital

Suspended

Efficacy of Artesunate + Amodiaquine Four Years After Its Introduction in Zanzibar

Malaria

Tanzania
Point Biomedical

Completed

Dose Finding Study of PB127 Ultrasound Contrast Agent in Healthy Volunteers and Patients With Coronary Artery Disease

Coronary Artery Disease | Healthy

United States
Sanofi

Completed

ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum Malaria

Malaria

Cameroon, Madagascar, Mali, Senegal
Institut de Recherche pour le Developpement

Completed

Treatment of Uncomplicated Malaria in Benin

Uncomplicated Malaria

Benin
Sanofi

Completed

Arsucam® (Artesunate + Amiodaquine) Efficacy and TOLerance (ATOL)

Malaria

Cameroon, Senegal
Bandim Health Project

Completed

Chloroquine and Amodiaquine for Treatment of Malaria in Children

Malaria, Falciparum

Guinea-Bissau
BioWest Therapeutics Inc

Unknown

A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C

Chronic Hepatitis C

Canada
Astellas Pharma Inc

Completed

Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis

Keratoconjunctivitis | Conjunctivitis

Japan
Sanofi

Completed

The Incidence of Hypoglycemia in Insulin Glargine-Treated Subjects With Diabetes Mellitus Upon Switching Between Bedtime and Morning Dosing

Diabetes Mellitus

Mexico
Abbott

Completed

A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension Medications

Healthy

United States
Abbott

Completed

A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amoxicillin Antibiotic Suspension Medications

Healthy

United States
Abbott

Completed

A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amoxicillin/Clavulanate in Pediatric Subjects With Acute Otitis Media

Acute Otitis Media

United States
Abbott

Completed

A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis Media

Acute Otitis Media

United States
Abbott

Completed

Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic Suspension Medications

Healthy

United States
Abbott

Completed

Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis Media

Acute Otitis Media

Costa Rica, United States, Guatemala, Israel, Chile, Dominican Republic, Panama
Hamilton Health Sciences Corporation

Unknown

Naproxen for Acute Pain After Surgery: A Randomized, Placebo-Controlled Trial (NAPS)

Pain, Postoperative

Canada
Skane University Hospital
Medical Research Council; Skane County Council Research & Development Foundation

Completed

Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes

Type 2 Diabetes | Secondary Drug Failure

Sweden
Oakwood Laboratories, LLC

Completed

Clinical Trial for Prostate Cancer

Prostate Cancer
Dafra Pharma
Kenya Medical Research Institute

Completed

Randomised Efficacy Study of Two Artemether-Lumefantrine Oral Formulations for the Treatment of Uncomplicated P. Falciparum Malaria

Malaria, Falciparum

Kenya
Accentia Biopharmaceuticals

Completed

Amphotericin B Suspension in Refractory Chronic Sinusitis

Chronic Sinusitis

United States
Bernhard Nocht Institute for Tropical Medicine
Kumasi Centre for Collaborative Research (KCCR); Presbyterian Health Service... and other collaborators

Terminated

Randomized Trial on Effectiveness of ACTs in Ghana

Malaria, Falciparum

Ghana

3

Subscribe